Bolt Biotherapeutics, Inc.
USD3.88
-0.03 (-0.64%)
CEO
William Quinn
IPO Date
2021-02-05
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$3.92
Prev. Close
$3.90
Day Low
$3.86
Day High
$4.19
52W Low
$3.75
52W High
$7.20
Market Cap
$0.01B
Volume
0.01M
| -6.5 |
| 31 Dec 2023 | FY | -681.4% | -878.6% | -61.4% | -43.3% | 0.18 | 5.17 | -12.2 |
| 31 Dec 2022 | FY | -1176.4% | -1537.8% | -51.4% | -38.7% | 0.13 | 7.47 | -11.0 |
| 31 Dec 2021 | FY | -5904.4% | -7824.7% | -39.4% | -32.0% | 0.10 | 8.87 | -37.2 |
| 31 Dec 2020 | FY | -17370.6% | -26289.2% | 57.9% | -130.5% | -0.10 | 2.25 | -383.8 |
| 31 Dec 2019 | FY | 100.0% | -14180.0% | 66.5% | -62.9% | -0.22 | 4.15 | -168.9 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | 72.7% | -72.5% | -0.00 | 5.12 | -107.8 |
| -0.4 |
| 30 Sept 2025 | Q3 | 100.0% | -329.4% | -22.3% | -11.0% | 0.73 | 3.57 | -0.4 |
| 30 Jun 2025 | Q2 | 100.0% | -474.6% | -22.0% | -11.3% | 0.62 | 3.11 | -0.3 |
| 31 Mar 2025 | Q1 | 100.0% | -903.4% | -23.6% | -12.9% | 0.53 | 3.13 | -6.9 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -27.9% | -16.0% | 0.44 | 3.20 | -6.4 |
| 30 Sept 2024 | Q3 | 100.0% | -1330.1% | -21.1% | -13.9% | 0.25 | 3.16 | -8.2 |
| 30 Jun 2024 | Q2 | 100.0% | -1662.4% | -24.7% | -17.1% | 0.22 | 4.28 | -6.6 |
| 31 Mar 2024 | Q1 | 91.3% | -205.0% | -10.4% | -7.6% | 0.19 | 5.68 | -26.4 |
| 31 Dec 2023 | Q4 | -681.3% | -857.0% | -15.9% | -11.2% | 0.18 | 5.17 | -11.9 |